SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes.

Tomás P. Griffin,Sean F. Dinneen

SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes.

2020

Tomás P. Griffin
Sean F. Dinneen

SOURCE CITATION Liu J, Li L, Li S, et al. Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2020;22:1619-27. 32364674.

Keywords:

Medicine
Type 2 diabetes
Randomized controlled trial
Internal medicine
Diabetes mellitus
Diabetic ketoacidosis
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations